We talked to Denis Angioletti, CCO at Cerbios-Pharma about Cerbios key values, their most recent investment for the development and manufacturing of ADCs, technologies and strategies.
TWENTYFOURSEVENBIOPHARMA
We talked to Denis Angioletti, CCO at Cerbios-Pharma about Cerbios key values, their most recent investment for the development and manufacturing of ADCs, technologies and strategies.